Edition:
United Kingdom

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

30.16EUR
19 Oct 2018
Change (% chg)

€0.54 (+1.82%)
Prev Close
€29.62
Open
€29.52
Day's High
€30.18
Day's Low
€29.46
Volume
421,985
Avg. Vol
574,125
52-wk High
€40.80
52-wk Low
€27.49

Latest Key Developments (Source: Significant Developments)

Recordati H1 Net Profit up at Eur 164.2 Mln
Thursday, 26 Jul 2018 

July 26 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::H1 REVENUE EUR 696.1 MILLION VERSUS EUR 650.9 MILLION YEAR AGO.H1 NET PROFIT EUR 164.2 MILLION VERSUS EUR 147.0 MILLION YEAR AGO.CEO SAYS CO CONFIRMS TARGETS FOR FY 2018.  Full Article

Fimei Says Agreement For Sale Of Stake To CVC Values Recordati At EUR 28 /shr With Dividend
Monday, 2 Jul 2018 

July 2 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::FIMEI SAYS AGREEMENT FOR SALE OF FIMEI STAKE TO CVC CAPITAL PARTNERS IMPLIES VALUE OF EUR 28 PER RECORDATI SHARE CUM DIVIDEND.  Full Article

CVC agrees to acquire FIMEI S.p.A. for about EUR 3 bln
Friday, 29 Jun 2018 

June 29 (Reuters) - :RECORDATI- FIMEI REACHED AN AGREEMENT TO SELL THEIR ENTIRE SHAREHOLDING IN FIMEI TO A CONSORTIUM OF INVESTMENT FUNDS CONTROLLED BY CVC CAPITAL PARTNERS.TRANSACTION CONSIDERATION UNDER AGREEMENT IS APPROXIMATELY EUR 3 BILLION, IMPLYING A PRICE OF EUR 28 PER RECORDATI S.P.A. SHARE.CONSIDERATION WILL BE PAYABLE AS APPROXIMATELY EUR 2.3 BILLION IN CASH AND EUR 750 MILLION IN SUBORDINATED LONG-TERM DEBT SECURITIES.COMPLETION OF SALE OF FIMEI IS ANTICIPATED TO TAKE PLACE IN LAST QUARTER OF 2018.AGREEMENT IS SUBJECT ONLY TO INVESTORS RECEIVING REQUIRED ANTI-TRUST AND COMPETITION CLEARANCES IN RELEVANT JURISDICTIONS.  Full Article

Recordati shares suspended from trading pending statement - bourse
Friday, 29 Jun 2018 

June 29 (Reuters) - Recordati::MILAN STOCK EXCHANGE SAYS RECORDATI SHARES ARE SUSPENDED FROM AFTER-HOURS TRADING PENDING STATEMENT.  Full Article

Fimei Confirms Negotiations With CVC For Sale Of Recordati By Recordati Family
Wednesday, 20 Jun 2018 

June 20 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::FIMEI CONFIRMS THAT THERE ARE NEGOTIATIONS WITH CVC FUND FOR SALE BY RECORDATI FAMILY OF INDIRECT CONTROL OF RECORDATI.FIMEI ADDS THERE ARE 'MANY' OBSTACLES TO OVERCOME AND THERE IS NO CERTAINTY OVER PROSECUTION OF NEGOTIATIONS AND THEIR TIMING.  Full Article

Recordati Q1 Net Profit Up At EUR 86.6 Mln
Tuesday, 8 May 2018 

May 8 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA ::Q1 REVENUE EUR 366.5 MILLION VERSUS EUR 341.9 MILLION YEAR AGO.Q1 NET PROFIT EUR 86.6 MILLION VERSUS EUR 78.5 MILLION YEAR AGO.CONFIRMS 2018 TARGETS.  Full Article

Recordati Q3 net profit up at EUR ‍​72.8 mln, confirms FY targets
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - RECORDATI ::Q3 NET PROFIT EUR ‍​72.8 MILLION VERSUS EUR 59.6 MILLION YEAR AGO.Q3 REVENUE EUR 313.0 ‍​MILLION VERSUS EUR 274.5 MILLION YEAR AGO.INTERIM 2017 DIVIDEND OF EUR 0.42 PER SHARE TO BE DISTRIBUTED‍​.CONFIRMS FY 2017 TARGETS.  Full Article

Recordati: European Commission approves Reagila as schizophrenia treatment
Wednesday, 19 Jul 2017 

July 19 (Reuters) - RECORDATI SPA ::EUROPEAN COMMISSION APPROVES REAGILA (CARIPRAZINE) FOR TREATMENT OF SCHIZOPHRENIA.  Full Article